Farah Yehia, PhD

Articles by Farah Yehia, PhD

Predictors of Orphan Drug Coverage Restrictions in Medicare Part D

ByFarah Yehia, PhD,Jodi B. Segal, MD, MPH,Gerard F. Anderson, PhD

September 8th 2020

The majority of orphan drugs are subject to utilization controls in Medicare Part D plans. The use of utilization controls varies by certain drug characteristics.

Latest Updated Articles

Predictors of Orphan Drug Coverage Restrictions in Medicare Part D
September 8th 2020

Farah Yehia, PhD

Articles by Farah Yehia, PhD

Predictors of Orphan Drug Coverage Restrictions in Medicare Part D

Latest Updated Articles

Trending on AJMC

Multiagonists Outpace Older GLP-1 Drugs for Weight Loss

How Long-Acting Injectables Are Changing HIV Care

Less-Intensive Leukemia Regimen Outperforms Standard Chemo

Inside Myeloma’s Evolution From Death Sentence to Cure

Evolocumab Cuts Death Risk for a First Heart Attack or Stroke